We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Sector Composition

Rank Sector Weight
1 Technology 21.24%
2 Consumer Discretionary 7.38%
3 Financials 6.38%
4 Healthcare 5.93%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AIMD icon
4176
Ainos
AIMD
$10.4M
$11K ﹤0.01%
486
+132
+37% +$2.65K
AL
4177
DELISTED
Air Lease Corp
AL
$11K ﹤0.01%
270
-1,470
-84% -$61.5K
AQST icon
4178
Aquestive Therapeutics
AQST
$522M
$11K ﹤0.01%
9,282
+4,287
+86% +$3.71K
AREN icon
4179
Arena Group
AREN
$55.2M
$11K ﹤0.01%
2,702
+1,856
+219% +$14.1K
ARL icon
4180
American Realty Investors
ARL
$246M
$11K ﹤0.01%
416
-35
-8% -$892
ARTW icon
4181
Arts-Way Manufacturing Co
ARTW
$16.1M
$11K ﹤0.01%
5,788
-706
-11% -$1.58K
AVAH icon
4182
Aveanna Healthcare
AVAH
$2.68B
$11K ﹤0.01%
10,915
-4,232
-28% -$5.03K
AVIR icon
4183
Atea Pharmaceuticals
AVIR
$411M
$11K ﹤0.01%
3,156
-17,888
-85% -$72.6K
KEEL
4184
Keel Infrastructure Corp
KEEL
$2.17B
$11K ﹤0.01%
11,552
-2,934
-20% -$2.74K
BPRN icon
4185
Princeton Bancorp
BPRN
$295M
$11K ﹤0.01%
360
-40
-10% -$1.34K
BRT
4186
BRT Apartments
BRT
$271M
$11K ﹤0.01%
550
-438
-44% -$8.91K
BTBD icon
4187
BT Brands
BTBD
$7.92M
$11K ﹤0.01%
3,925
-1,571
-29% -$3.4K
CCEL icon
4188
Cryo-Cell International
CCEL
$32.3M
$11K ﹤0.01%
3,657
+1,548
+73% +$5.97K
CFLT
4189
DELISTED
Confluent
CFLT
$11K ﹤0.01%
484
-4,624
-91% -$107K
CGTX icon
4190
Cognition Therapeutics
CGTX
$96M
$11K ﹤0.01%
5,325
+1,131
+27% +$2.15K
CHCI icon
4191
Comstock Holding Companies
CHCI
$178M
$11K ﹤0.01%
2,162
+535
+33% +$2.55K
CING icon
4192
Cingulate
CING
$65.7M
$11K ﹤0.01%
45
+7
+18% +$1.86K
CMCT
4193
Creative Media & Community Trust
CMCT
$14M
0
CNA icon
4194
CNA Financial
CNA
$13.8B
$11K ﹤0.01%
283
-1,672
-86% -$70.1K
CPIX icon
4195
Cumberland Pharmaceuticals
CPIX
$117M
$11K ﹤0.01%
5,930
+2,463
+71% +$5.86K
CRVS icon
4196
Corvus Pharmaceuticals
CRVS
$1.23B
$11K ﹤0.01%
12,597
-121
-1% -$94
CTGO icon
4197
Contango Silver & Gold Inc
CTGO
$669M
$11K ﹤0.01%
369
+87
+31% +$2.11K
CVAC
4198
DELISTED
CureVac
CVAC
$11K ﹤0.01%
1,534
-4,674
-75% -$40.7K
MYSE
4199
Myseum.AI Inc
MYSE
$13.6M
$11K ﹤0.01%
1,994
-180
-8% -$1.08K
DDIV icon
4200
First Trust Exchange-Traded Fund VI First Trust Dorsey Wright Momentum & Dividend ETF
DDIV
$81.2M
$11K ﹤0.01%
+407
New +$11.8K

Similar funds

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.